EDMONTON, Alberta, Nov. 6 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that it has begun working with U.S. based Companies to expand its distribution network worldwide. These companies have established distribution networks and are interested in carrying the VScan products and will be working with the Company to help clear the products for sale in the United States. The Company expects to sell an additional 800,000 kits in the first year. One of the reasons for this interest, is that the Company has received independent test results that show that its VScan HIV rapid test kit is more effective than the Elisa test for HIV testing. The Elisa test is considered the "GOLD" standard for HIV testing. It is the test that all other tests are compared to. The Elisa test requires medical facilities and takes three days. The VScan HIV test kit dies not require medical facilities and is particularly accurate using "whole "blood. It can be used in remote areas under any circumstances. Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright